In summary, Jonsson et al. have made a significant contribution to the debate on the involvement of BRCA1 and BRCA2 variants to melanoma predisposition and provide a reminder that we must constantly revisit gene‐disease associations so as to better counsel patients about their care. The gene discussed is BRCA1; the disease is melanoma.